30
/pt/
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
June 15, 2024
5819813
551854
1
Public Timelines
FAQ
Menu
Public Timelines
FAQ
Public Timelines
FAQ
For education
For educational institutions
For teachers
For students
Open cabinet
For educational institutions
For teachers
For students
Open cabinet
Criar
Close
Create a timeline
Public timelines
Library
FAQ
21 jul 2020 ano - AstraZeneca’s Phase I/II clinical trial for AZD1222 demonstrated a robust immune response (neutralizing antibody levels).
Adicionado na linha do tempo:
COVID 2020 - Policy, vaccines, therapies, and testing
By
MedicalGold.ca
16 set 2021
0
0
566
Data:
21 jul 2020 ano
Agora
~ 3 years and 10 months ago
About & Feedback
Acordo
Privacidade
Biblioteca
2024
©
Time.Graphics
Support 24/7
Cabinet
Get premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL
Excellent (Trustpilot Reviews)
Based on 115+ reviews
